Congress Feature: ESC Congress Update on ESC/EACTS 2025 Valvular Heart Disease Guidelines: Establishing the Present and Designing the Future for the Therapy of the Aortic Valve

AT THIS YEAR’S European Society of Cardiology (ESC) Congress held in Madrid, Spain, more than 40,000 participants shared updates over a full 4-day programme. Several new guidelines were presented, aiming to provide timely recommendations that assist clinical decision-making in everyday practice. In this context, the much-awaited update on the guidelines for the management of valvular heart disease was announced,1 which was jointly endorsed by ESC and the European Association for Cardiothoracic Surgery (EACTS), and included several updates from older versions, as well as a total of 28 new recommendations. This feature aims to summarise the most important updates in the aortic valve interventions.